Targeting the Human β

Animals Cytokines Dermatitis, Contact Eosinophils Granulocyte-Macrophage Colony-Stimulating Factor / metabolism Humans Interleukin-3 / metabolism Interleukin-5 / metabolism Mice Mice, Transgenic

Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
04 2022
Historique:
received: 25 02 2021
revised: 15 07 2021
accepted: 21 07 2021
pubmed: 20 9 2021
medline: 10 5 2022
entrez: 19 9 2021
Statut: ppublish

Résumé

Allergic contact dermatitis (ACD) is a prevalent and poorly controlled inflammatory disease caused by skin infiltration of T cells and granulocytes. The beta common (β

Identifiants

DOI: 10.1016/j.jid.2021.07.183 PMID: 34537191
pubmed: 34537191
pii: S0022-202X(21)02214-4
doi: 10.1016/j.jid.2021.07.183
pii:
doi:

Substances chimiques

Cytokines 0
Interleukin-3 0
Interleukin-5 0
Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1103-1113.e11

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Kwok Ho Yip (KH)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Duncan McKenzie (D)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Hayley S Ramshaw (HS)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Jessica Chao (J)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Barbara J McClure (BJ)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Elmar Raquet (E)

Research & Development, CSL Behring, Marburg, Germany.

Timo Kraushaar (T)

Research & Development, CSL Behring, Marburg, Germany.

Joachim Röder (J)

Research & Development, CSL Behring, Marburg, Germany.

Mhairi Maxwell (M)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Monther Alhamdoosh (M)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Andrew Hammet (A)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Jia Hong Fong (JH)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Kathleen Zeglinski (K)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Katherine Monaghan (K)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Harshita Pant (H)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Michele A Grimbaldeston (MA)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; OMNI Biomarker Development, Genentech, Inc, South San Francisco, California, USA.

Gino Vairo (G)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Nicholas J Wilson (NJ)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Catherine M Owczarek (CM)

Research & Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.

Timothy R Hercus (TR)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Angel F Lopez (AF)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia. Electronic address: angel.lopez@sa.gov.au.

Damon J Tumes (DJ)

Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Targeting the Human β
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Targeting the Human β
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Dermatoses eczémateuses › Eczéma de contact › Targeting the Human β
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Granulocytes › Granulocytes éosinophiles › Targeting the Human β
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de croissance hématopoïétique › Facteurs de stimulation des colonies › Facteur de stimulation des colonies de granulocytes et de macrophages › Targeting the Human β
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Targeting the Human β
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-3 › Targeting the Human β
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-5 › Targeting the Human β
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Targeting the Human β
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Targeting the Human β